West Pharmaceutical authorizes repurchase of up to 550,000 shares

WEST PHARMACEUTICAL SERVICES INC

Board approved new share repurchase program on Dec 9, 2024, authorizing up to 550,000 shares.
Repurchases may be made on open market or in private transactions under Rule 10b-18.
Program expected to be completed by December 31, 2025.
Existing repurchase program expires at end of 2024.
Repurchase timing and number depend on market conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.